Phenomenal data and unique insights from @charlesswanton.bsky.social and colleagues. Bravo!
NEW Nature study helps explain why immunotherapy has struggled in #EGFR+ #lungcancer. Research shows tumours can change under TKI treatment & immune pressure, losing markers that help the immune system recognise them.

www.nature.com/articles/s41...

#LCSM

Comments